Dan B. Prelusky

Excretion profiles of the mycotoxin deoxynivalenol, following oral and intravenous administration to sheep☆

The excretion profiles of deoxynivalenol (DON) and metabolites (DON glucuronide conjugate, 3 alpha, 7 alpha,15-trihydroxytrichothec-9,12-diene-8-one (DOM-1), and DOM-1 glucuronide conjugate) were defined in male sheep following either intravenous (iv) or oral administration of the toxin at levels of 0.5 and 5.0 mg DON/kg body wt, respectively. After iv dosing, urinary DON levels declined in a biphasic fashion with an average elimination half-life (terminal phase) of 1.2 hr, diminishing to baseline concentrations by 8 hr. Maximum urinary excretion rates for the two major metabolites identified (conjugated DON, conjugated DOM-1) occurred 0.5-1.5 hr after dosing, exhibiting elimination half-lives of 2.2 and 3.1 hr, respectively. Total recovery accounted for only about 66.5% of the dose: 63.0% in the urine (24.1% DON, 21.2% conjugated DON, 0.5% DOM-1, 17.2% conjugated DOM-1) and 3.5% in bile (made up almost completely of conjugated DOM-1). The peak biliary excretion rate for conjugated DOM-1 was found to occur within 1 hr postdosing, which rapidly declined to baseline levels by 5 hr. Following oral administration, urinary excretion rates of the major metabolites (DON, conjugated DON, conjugated DOM-1) reached maximum 6-9 hr post-treatment, and declined exponentially with t 1/2 values of 3.2, 4.0, and 5.0 hr, respectively. Urinary and biliary recovery of administered DON averaged approximately 7.1%: 7.0% in urine (2.1% DON, 3.6% conjugated DON, 0.06% DOM-1, 1.2% conjugated DOM-1) and 0.11% in bile (predominantly conjugated DOM-1).(ABSTRACT TRUNCATED AT 250 WORDS)

Sensitive analysis of the mycotoxin zearalenone and its metabolites in biological fluids by high-performance liquid chromatography☆

A method is described for the analysis of zearalenone and its metabolites, alpha- and beta-zearalenol, in small volumes (0.5-2.0 ml) of biological fluids including milk, blood, plasma, urine and bile, using high-performance liquid chromatography with fluorescence detection. Isolation of the toxins from biological fluids was achieved using a series of pH-controlled solvent extractions. Detection limits for zearalenone and alpha-zearalenol were 1 ng/ml, and for beta-zearalenol ca. 5 ng/ml, both at a signal-to-noise ratio of 3. In bile, however, the detection was ca. five times less sensitive owing to interfering substances. Recoveries at low ng/ml concentrations were highest from urine (87-94%) and plasma (85-93%), slightly lower from whole blood (78-88%) and milk (75-84%), and lowest from bile (66-77%).